ClinicalTrials.gov
ClinicalTrials.gov Menu

TCR-Redirected T Cell Infusions to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02686372
Recruitment Status : Recruiting
First Posted : February 19, 2016
Last Update Posted : March 22, 2016
Sponsor:
Collaborators:
First Affiliated Hospital, Sun Yat-Sen University
Agency for Science, Technology and Research
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Information provided by (Responsible Party):
Lion TCR Pte. Ltd.